[The effect of docetaxel on malignant tumors]

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Recent molecular discoveries have identified new targets for anticancer drug development.
• Taxanes, which inhibit tubulin depolymerization crucial for cell division, are important therapeutic agents.
• Docetaxel (Taxotere) is a taxane used in cancer treatment, including breast cancer.

Purpose of the Study:

• To review the role of Docetaxel (Taxotere) in cancer therapy.
• To highlight its efficacy in various cancer types and its potential in combination chemotherapy.
• To discuss the management of its toxicity and its overall therapeutic perspective.

Main Methods:

• Literature review of molecular biology discoveries and clinical applications of Docetaxel.
• Analysis of Docetaxel's mechanism of action on tubulin.
• Evaluation of clinical data regarding its efficacy and toxicity in different cancers.

Main Results:

• Docetaxel demonstrates efficacy in breast cancer, including platinum-resistant cases.
• Visceral metastases, such as hepatic metastases, may respond to Docetaxel therapy.
• Combination chemotherapy regimens involving Docetaxel show promising results.
• The antitumoral effects in non-small cell lung cancer (NSCLC) and other neoplasms are under investigation.
• Steroid premedication effectively reduces Docetaxel toxicity.

Conclusions:

• Docetaxel is a valuable chemotherapeutic agent with a broad spectrum of activity.
• Management of toxicity through premedication ensures safe and effective treatment.
• Docetaxel represents a promising therapeutic option in oncology, with ongoing research expanding its applications.